DNSK reports FDA approval of new chemical entity
DNSK International reports approval of UKONIQTM (aka Umbralisib, TGR1202, RP-5264) for the treatment of marginal zone lymphoma and follicular lymphoma. Since 2010 DNSK has been working...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
DNSK International reports approval of UKONIQTM (aka Umbralisib, TGR1202, RP-5264) for the treatment of marginal zone lymphoma and follicular lymphoma. Since 2010 DNSK has been working...
One of the larger undeveloped parcels in Windsor’s Great Pond business park may soon be transformed into a major biotech research and development hub. The...
UConn’s Technology Incubation Program (TIP) is expanding to Stamford with a new location focused on data science startups … more Technology Commercialization Services’ (TCS) Mostafa...
Connecticut Innovations (CI), Connecticut’s strategic venture capital arm, has announced an effort to promote Connecticut’s life sciences ecosystem. The effort, “Connecticut: Where Science Lives,” highlights the...
Cybrexa Therapeutics has completed the GLP toxicology study of its lead candidate, CBX-12. The positive results for this study serve as a guide for dosing...
Following Connecticut Governor Ned Lamont’s budget address to members of the General Assembly, BioCT’s President and CEO, Dawn Hocevar, issued the following statement. Imposing arbitrary...
Bristol Myers Squibb has secured global rights to a pair of anti-SARS-CoV-2 antibodies discovered by The Rockefeller University. The antibodies entered phase 1 development last...
Sema4 and CM Life Sciences have entered into a definitive business combination agreement. Upon closing, CM Life Sciences will be renamed and its common stock...
Meet New Haven Biz’s 2021 Power 25. If there is anything the coronavirus pandemic has taught us, it’s the need for smart, competent and honest...
Did you miss the BioCT Directors Series presentation, hosted by Mostafa Analoui, Ph.D., exploring the broad range of investment vehicles available to life sciences innovators? To...